ArticleEClinicalMedicine2023

Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study.

Xiaoyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.